Effects of nicotinamide mononucleotide on older patients with diabetes and impaired physical performance: A prospective, placebo-controlled, double-blind study.
Hiroshi AkasakaHironori NakagamiKen SugimotoYukiko YasunobeTomohiro MinamiTaku FujimotoKoichi YamamotoChikako HaraAkihiko ShirakiKohji NishidaKento AsanoMasanobu KanouKei YamanaShin-Ichiro ImaiHiromi RakugiPublished in: Geriatrics & gerontology international (2022)
In older male patients with diabetes and impaired physical performance, NMN supplementation for 24 weeks was safe, but did not improve grip strength and walking speed. Geriatr Gerontol Int 2022; ••: ••-••.